Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation.
- DOI
- 10.1016/j.euo.2023.05.013
- Published
- 2024 Feb
- Container
- European urology oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.euo.2023.05.013,
title = {Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation.},
author = {Dahl DM and Karrison TG and Michaelson MD and Pham HT and Wu CL and Swanson GP and Shipley WU and Vuky J and Lee RJ and Zietman AL and Souhami L and Chang BK and Deming RL and Ellerton JA and Sandler HM and Rodgers JP and Feng FY and Efstathiou JA},
year = {2024},
journal = {European urology oncology},
doi = {10.1016/j.euo.2023.05.013},
url = {https://doi.org/10.1016/j.euo.2023.05.013}
}RIS
TY - JOUR TI - Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation. AU - Dahl DM AU - Karrison TG AU - Michaelson MD AU - Pham HT AU - Wu CL AU - Swanson GP AU - Shipley WU AU - Vuky J AU - Lee RJ AU - Zietman AL AU - Souhami L AU - Chang BK AU - Deming RL AU - Ellerton JA AU - Sandler HM AU - Rodgers JP AU - Feng FY AU - Efstathiou JA PY - 2024 JO - European urology oncology DO - 10.1016/j.euo.2023.05.013 UR - https://doi.org/10.1016/j.euo.2023.05.013 ER -
APA
DM, D., TG, K., MD, M., HT, P., CL, W., GP, S., WU, S., J, V., RJ, L., AL, Z., L, S., BK, C., RL, D., JA, E., HM, S., JP, R., FY, F., & JA, E. (2024). Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation.. European urology oncology. https://doi.org/10.1016/j.euo.2023.05.013
Source records
- pubmed · retrieved 2026-09-26T17:12:39.604Z